APA (7th ed.) Citation

Y, M., & M, N. (2019). ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes. Annals of surgical oncology, 26(Suppl 3), 739. https://doi.org/10.1245/s10434-019-07857-z

Chicago Style (17th ed.) Citation

Y, Miyasaka, and Nakamura M. "ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes." Annals of Surgical Oncology 26, no. Suppl 3 (2019): 739. https://doi.org/10.1245/s10434-019-07857-z.

MLA (9th ed.) Citation

Y, Miyasaka, and Nakamura M. "ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes." Annals of Surgical Oncology, vol. 26, no. Suppl 3, 2019, p. 739, https://doi.org/10.1245/s10434-019-07857-z.